Trademark: 79192016
Status Date
Friday, September 23, 2022
Registration Number
5220372
Registration Date
Tuesday, June 13, 2017
Filing Date
Tuesday, July 19, 2016
Published for Opposition
Tuesday, March 28, 2017
Cancellation Date
Friday, September 23, 2022
5 Pharmaceutical products, namely, pharmaceutical preparations containing hydrocortisone for endocrinologic disorders
Oct 9, 2022
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Oct 9, 2022
Death Of International Registration
Jun 13, 2022
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Oct 28, 2017
Final Decision Transaction Processed By Ib
Sep 18, 2017
Final Disposition Notice Sent To Ib
Sep 18, 2017
Final Disposition Processed
Sep 13, 2017
Final Disposition Notice Created, To Be Sent To Ib
Jun 13, 2017
Registered-Principal Register
Mar 28, 2017
Official Gazette Publication Confirmation E-Mailed
Mar 28, 2017
Published For Opposition
Mar 25, 2017
Notification Processed By Ib
Mar 8, 2017
Notification Of Possible Opposition Sent To Ib
Mar 8, 2017
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 8, 2017
Notification Of Notice Of Publication E-Mailed
Feb 22, 2017
Law Office Publication Review Completed
Feb 10, 2017
Approved For Pub - Principal Register
Feb 10, 2017
Teas/Email Correspondence Entered
Feb 10, 2017
Correspondence Received In Law Office
Feb 7, 2017
Assigned To Lie
Jan 24, 2017
Teas Response To Office Action Received
Nov 18, 2016
Refusal Processed By Ib
Nov 2, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Nov 2, 2016
Refusal Processed By Mpu
Nov 1, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Oct 31, 2016
Non-Final Action Written
Oct 29, 2016
Assigned To Examiner
Oct 1, 2016
Application Filing Receipt Mailed
Sep 27, 2016
New Application Office Supplied Data Entered In Tram
Sep 26, 2016
Limitation From Original Application Entered
Sep 22, 2016
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
